Most hospitals say the same things in their marketing:
“We’re leaders in quality.”
“World-class care.”
“Clinical excellence.”
The problem isn’t that it’s false. The problem is that it’s invisible.
In 2026, “quality” as an abstract concept doesn’t compete against:
- public comparisons,
- reviews,
- social narratives,
- and metrics that can actually be measured.
In fact, there’s evidence that patient-experience data (like HCAHPS) and narrative
stories (“they treated me terribly” / “they saved my life”) can influence hospital
choice in comparable ways. (PubMed)
The executive-level question is simple:
Are you selling “promises”… or are you selling “results”?
The angle: ethical healthcare marketing (no hype, no “miracles,” no unsupported claims)
Healthcare marketing isn’t like selling sneakers. There’s a red line: you can’t
imply guaranteed outcomes, exaggerate, or hide material conditions.
- The AMA is blunt: physician advertising must be truthful and not
materially misleading; and objective claims about quality should only be
made if they are factually supportable. (code-medical-ethics.ama-
assn.org) - The FTC reinforces the foundational principle of truth-in-advertising:
objective claims must be substantiated before you publish them.
(Federal Trade Commission)
Translation for marketing + leadership: if you want to say “our infection rate is
exceptionally low,” great—but back it with methodology, time period, denominator,
and evidence.
The thesis: stop selling “quality.” Sell results (clearly and responsibly)
“Quality” becomes powerful when it turns into a verifiable promise, for example:
- Safety: healthcare-associated infections, complications, adverse events
- Outcomes: risk-adjusted mortality, readmissions, length of stay
- Experience: communication, timeliness, recommendation, trust
- Efficiency: access, OR on-time starts, cancellations, throughput
AHRQ maintains indicator sets (Quality Indicators / Patient Safety Indicators) that
have been considered suitable for consumer-oriented reporting. (ahrq.gov)
CMS also publishes patient-experience results (HCAHPS) publicly through Care Compare. (CMS)
What you can say (and what you should avoid)
Claims that work (and are defensible)
As long as you provide context and substantiation:
- “Our surgical site infection rate for [Procedure X] is below the benchmark
during [Q1–Q4 2026].” - “We reduced [Metric] by [X%] over 12 months.”
- “Our patient-experience score for [Dimension] has remained consistently in
[Range] based on a standardized survey.”
CMS uses HAI measures derived from NHSN (CDC), including colon surgery and
hysterectomy SSI measures, within measurement programs. (CMS)
Claims that are legal + reputational landmines
- “Zero infections” (often reads like an absolute promise).
- “We guarantee outcomes.”
- “We’re the best” with no source.
- Testimonials that imply everyone will achieve the same outcome (the AMA
warns testimonials can be misleading if they don’t represent typical results).
(code-medical-ethics.ama-assn.org)
The framework: Evidence-Based Marketing (EBMKT) in 5 steps
1) Define your “outcome offer”
- “Joint replacement with a safety + recovery focus”
- “Bariatric surgery with structured follow-up and control”
- “Cardiology with optimized door-to-balloon times” (when applicable)
2) Choose 3–5 metrics that matter to patients and payers
Examples (select based on your service lines and reality):
- infections / complications (with definitions and, when possible, risk adjustment)
- readmissions
- average length of stay
- satisfaction / experience (HCAHPS or another standardized tool)
- access / waiting times
3) Standardize definitions (so this isn’t “creative marketing”)
For infections, for instance, surveillance commonly uses constructs like the SIR
(Standardized Infection Ratio) in NHSN methodology—observed vs expected,
adjusted for risk. (Salud Pública SC)
4) Turn metrics into stories (without manipulating)
Patients don’t buy an “SIR.” They buy peace of mind.
A responsible narrative looks like:
- “We measure infections with standardized methodology and review every
case.” - “We publish results by time period and explain how to interpret them.”
5) Publish with operational transparency
Always include:
- time period (e.g., “Jan–Dec 2026”)
- population size (n)
- indicator definition
- and when relevant: risk adjustment and limitations
This doesn’t weaken your marketing. It makes it credible.
The sensitive part: privacy and data use (so you don’t create a compliance
problem)
If you use clinical data in public communication, two golden rules apply:
Don’t use PHI in marketing without a legal basis/authorization
HHS explains that “marketing” under HIPAA often requires authorization if
it involves PHI, with specific exceptions. (HHS.gov)
When publishing outcomes, publish aggregated or de-identified data
Regulations (45 CFR 164.514) describe de-identification methods,
including Safe Harbor (removing identifiers) or expert determination. (LII)
Quick compliance-friendly checklist:
- Could anyone be identified directly or indirectly? If yes: stop.
- Is the metric aggregated with a sufficient n? Good.
- Is the claim verifiable and supportable? Good.
- Does the copy avoid guaranteeing outcomes? Good.
Where HarmoniMD fits: from “locked data” to evidence-based campaigns
This is where a HIS stops being “documentation software” and becomes a commercial + reputational engine.
1) Clinical BI that marketing can actually defend
HarmoniMD describes data-driven decision-making via reports and visualizations to identify trends and projections. (Harmoni MD)
Its clinical modules also reference reports and statistics for analysis and continuous improvement. (Harmoni MD)
In practice, this enables you to:
- segment by service line / provider / procedure
- identify consistent outcomes (not “one-off hero cases”)
- document before/after improvements (ideal for campaigns)
2) CLARA: less friction turning data into clear messaging
CLARA is presented as an integrated assistant capable of analyzing charts, summarizing clinical information, and supporting report writing for clinician review and sign-off. (Harmoni MD)
That accelerates the bridge from “operations → evidence → communication,”
without making clinicians feel like marketing is stealing their time.
Conclusion: OR schedules don’t fill with slogans—they fill with verifiable trust
In 2026, winning hospital marketing isn’t the loudest “we’re excellent.” It’s the one that explains:
- what it measures,
- how it measures it,
- what results it achieves,
- and what it’s doing to improve.
That’s ethical. That’s defensible. And it converts because trust has ROI.
If you want to see how HarmoniMD (HIS) + CLARA can help you transform
clinical records into actionable Business Intelligence (for quality, operations…
and evidence-based marketing), book a demo. We’ll review your priority service
lines, your current indicators, and a roadmap to publish outcomes with rigor, clarity,
and compliance.